The SCICONX Journal of Pharmaceutical Chemistry and Biopharmaceutics (JPCB) is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research that advances the fields of pharmaceutical chemistry, drug development, and biopharmaceutics. The journal serves as a dynamic platform for scientists, clinicians, and industry professionals to share novel discoveries, innovative methodologies, and comprehensive reviews that contribute to the understanding and improvement of drug design, formulation, and therapeutic application.

✦ Aim of the Journal

JPCB aims to bridge the gap between fundamental pharmaceutical science and clinical application. The journal provides a forum for interdisciplinary research that enhances drug efficacy, safety, and patient outcomes. Our primary objective is to promote innovation in drug discovery, molecular design, formulation strategies, and biopharmaceutical evaluation, supporting the global scientific community in addressing current and emerging healthcare challenges.

✦ Scope of the Journal

JPCB welcomes original research, reviews, short communications, and case studies in the following areas:

• Pharmaceutical Chemistry: Design, synthesis, structural characterization, and optimization of new drug candidates, including small molecules, peptides, and biologics.
• Drug Formulation & Delivery: Development of advanced delivery systems, controlled-release formulations, nanopharmaceuticals, and targeted therapies.
• Pharmacokinetics & Pharmacodynamics: Studies on absorption, distribution, metabolism, excretion (ADME), drug interactions, and efficacy evaluation.
• Biopharmaceutics: Investigations into drug bioavailability, stability, solubility, and transport mechanisms, including in vitro and in vivo modeling.
• Analytical & Computational Approaches: Application of molecular modeling, chemoinformatics, QSAR, and analytical techniques for drug characterization and optimization.
• Quality Control & Regulatory Science: Research on stability testing, good manufacturing practices, regulatory compliance, and risk assessment.
• Emerging Trends & Innovations: Cutting-edge research in personalized medicine, biopharmaceuticals, gene therapy, and translational drug development.

✦ Who Should Contribute

JPCB is designed for researchers, academicians, clinicians, and industry professionals seeking to share innovative work that advances pharmaceutical sciences and biopharmaceutics. We encourage contributions from all geographic regions and interdisciplinary backgrounds, fostering a global dialogue on drug discovery, development, and therapeutic innovation.

✦ Unique Focus

Unlike traditional pharmaceutical journals, JPCB emphasizes the integration of chemistry, formulation science, and biopharmaceutics to provide a holistic understanding of drug action and delivery. The journal prioritizes research that combines experimental rigor with translational relevance, ensuring that findings have both scientific significance and practical applicability.

The journal is committed to upholding the highest standards of scientific integrity, ethical publishing, and open access dissemination, ensuring that every contribution reaches a broad, international audience while advancing the frontiers of pharmaceutical research.